Login / Signup

Respiratory syncytial virus: challenges in diagnosis and impact on the elderly: Recommendations from a multidisciplinary panel.

Lessandra MichelinNancy Cristina Junqueira BelleiMarcelo Ferreira da Costa GomesSonia Maria RaboniMaisa KairallaRicardo de Amorim CorrêaMonica LeviAlberto ChebaboIsabella BallalaiSergio CimermanCecília Maria Roteli MartinsSusana Cristina Aidé Viviani FialhoMargareth Maria Pretti DalcolmoBruna M G de VerasRenato de Ávila KfouriOtávio Cintra
Published in: Human vaccines & immunotherapeutics (2024)
Respiratory syncytial virus (RSV) is an important cause of respiratory illness. While most attention is paid to childhood infection, the RSV burden in adults ≥60 y should also be considered. In Brazil, this is generally underrecognized, where greater focus is toward other respiratory pathogens. This article presents insights from a multidisciplinary panel gathered to review epidemiologic data and current diagnostic approaches to RSV in Brazil (and their limitations) and develop communication strategies to improve knowledge and awareness. National surveillance data indicate a steady increase in cases of RSV-related severe acute respiratory illness (RSV-SARI) in those aged ≥60 y in recent years, with high fatality rates (>30%). Routine RSV testing in older individuals with respiratory symptoms is relatively low. Educational activities targeted toward health-care professionals and the general public are critical to raising awareness of the importance of RSV in older individuals, particularly as protective vaccines are now available.
Keyphrases